Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
Academic rigour, journalistic flair
Articles on Drugs
Displaying 201 - 220 of 460 articles
Before being qualified as “magic”, certain mushrooms were considered sacred by the ancient peoples of Mexico. We explore their history and relationship to Mesoamerican religion and medicine.
Before marijuana was legalized, people argued over how it would affect taxes, crime and teens. But only now is there enough data to settle some of these debates.
Whistleblowing on doping can and does have life-altering implications for athletes – new research.
The UN’s new rights focus has the potential to overhaul the punitive nature of the war on drugs.
Baby boomers have shown the fastest rise in rates of alcohol and drug misuse in the last 15 years.
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
The technology to identify pills is getting cheaper and smaller. That means it could also be used to test the make-up of illegal pills at festivals and other events.
Artificially intelligent drug design programs could discover new therapies for conditions that are difficult or prohibitively expensive to cure.
A safety committee convened by the FDA has declared esketamine safe for severe depression. But isn’t this drug the same as ketamine, an illegal street drug? A medical anthropologist explains.
It’s ineffective to use drug dogs at festivals and in public places because they’re much more likely to catch small-time users than suppliers.
Understanding the pleasure drugs give people would help to prevent the harms.
A new study suggests that MDMA could be a useful therapeutic tool.
As politically polarized as the country may seem, when it comes to marijuana, Americans across the spectrum have changed their minds. A new study says it’s all thanks to the media.
Regional deprivation is causing thousands of northerners – especially men – to die young each year.
Buyers think you can tell the purity of a substance by looking at on an app – evidence shows they’re mistaken.
With its tales of bloody violence, corruption, international trade and entrepreneurial innovation, Guzmán’s trial offers a telenovela-style explainer on Mexican cartels and their American clients.
Unlicensed music events are on the rise again – and the free parties of the 1980s and 90s show they’re not all bad.
Media-driven panic about drugs can create a perception more people are using the drug than they actually are, and when teens think ‘everyone’ is doing it, they are more likely to want to do it too.
Gender and sexuality can help understand consent – but there’s so much more to consider, when drugs are involved.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Senior Lecturer of Addiction, Edith Cowan University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor in Substance Use, Liverpool John Moores University
-
Vice Chancellor’s Senior Research Fellow, Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University
-
Professor, Macquarie University
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Lecturer, RMIT University
-
University of Sydney
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway University of London
-
Senior Lecturer in Criminology, Deakin University
-
Professor & Specialist in Drug Policy, UNSW Sydney
